Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam flag Vietnam · Delayed Price · Currency is VND
49,900
+150 (0.30%)
At close: Apr 29, 2026

HOSE:DBD Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,872,4211,865,3801,727,5481,651,7701,554,8211,558,504
Revenue Growth (YoY)
4.91%7.98%4.59%6.24%-0.24%23.99%
Cost of Revenue
1,012,325981,001894,975853,250787,170935,939
Gross Profit
860,097884,379832,573798,520767,652622,566
Selling, General & Admin
540,306558,103526,981501,538494,312405,437
Operating Expenses
540,306558,103526,981501,538494,312405,437
Operating Income
319,791326,276305,592296,982273,339217,129
Interest Expense
-4,332-3,847-4,058-6,998-1,916-1,325
Interest & Investment Income
20,03620,03611,60511,6358,7335,137
Earnings From Equity Investments
13,99012,28027,06328,70424,78616,083
Currency Exchange Gain (Loss)
2,6442,644-947.49-482.96354.16733.11
Other Non Operating Income (Expenses)
-6,507-11,308-12,119-9,753-6,739-5,310
EBT Excluding Unusual Items
345,621346,082327,136320,086298,558232,448
Gain (Loss) on Sale of Investments
---2,000---
Pretax Income
345,621346,082325,136320,086298,558232,448
Income Tax Expense
54,39254,14249,95451,03155,00343,324
Net Income
291,229291,940275,182269,055243,555189,124
Preferred Dividends & Other Adjustments
40,91840,91838,52537,66834,09826,477
Net Income to Common
250,311251,022236,656231,387209,457162,646
Net Income Growth
0.76%6.09%2.28%10.47%28.78%19.80%
Shares Outstanding (Basic)
-9494949494
Shares Outstanding (Diluted)
-9494949494
Shares Change (YoY)
-0.34%--0.00%--0.07%
EPS (Basic)
-2673.962529.632473.312238.881738.52
EPS (Diluted)
-2673.962529.632473.002238.881738.52
EPS Growth
-5.71%2.29%10.46%28.78%17.16%
Free Cash Flow
82,883206,614115,985148,66382,18462,932
Free Cash Flow Per Share
-2200.911239.771589.06878.47672.68
Dividend Per Share
--2000.000-1600.000-
Gross Margin
45.93%47.41%48.19%48.34%49.37%39.95%
Operating Margin
17.08%17.49%17.69%17.98%17.58%13.93%
Profit Margin
13.37%13.46%13.70%14.01%13.47%10.44%
Free Cash Flow Margin
4.43%11.08%6.71%9.00%5.29%4.04%
EBITDA
366,673375,841353,705342,951315,005255,818
EBITDA Margin
19.58%20.15%20.47%20.76%20.26%16.41%
D&A For EBITDA
46,88249,56548,11245,97041,66538,689
EBIT
319,791326,276305,592296,982273,339217,129
EBIT Margin
17.08%17.49%17.69%17.98%17.58%13.93%
Effective Tax Rate
15.74%15.64%15.36%15.94%18.42%18.64%
Revenue as Reported
1,872,4211,865,3801,727,5481,651,7701,554,8211,558,504
Source: S&P Global Market Intelligence. Standard template. Financial Sources.